These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33050515)

  • 1. PARP1 Deficiency Reduces Tumour Growth by Decreasing E2F1 Hyperactivation: A Novel Mechanism in the Treatment of Cancer.
    Iglesias P; Seoane M; Golán I; Castro-Piedras I; Fraga M; Arce VM; Costoya JA
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Opportunity for "Old" Molecules: Targeting PARP1 Activity through a Non-Enzymatic Mechanism.
    Iglesias P; Seoane M; Golán-Cancela I; Fraga M; Arce VM; Costoya JA
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonstructural maintenance of chromatin condensin I complex subunit G promotes the progression of glioblastoma by facilitating Poly (ADP-ribose) polymerase 1-mediated E2F1 transactivation.
    Hou J; Huang P; Xu M; Wang H; Shao Y; Weng X; Liu Y; Chang H; Zhang L; Cui H
    Neuro Oncol; 2023 Nov; 25(11):2015-2027. PubMed ID: 37422706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human poly (ADP-ribose) polymerase 1 in Saccharomyces cerevisiae: Effect on survival, homologous recombination and identification of genes involved in intracellular localization.
    La Ferla M; Mercatanti A; Rocchi G; Lodovichi S; Cervelli T; Pignata L; Caligo MA; Galli A
    Mutat Res; 2015 Apr; 774():14-24. PubMed ID: 25779917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-Ribose) Glycohydrolase (PARG) vs. Poly(ADP-Ribose) Polymerase (PARP) - Function in Genome Maintenance and Relevance of Inhibitors for Anti-cancer Therapy.
    Harrision D; Gravells P; Thompson R; Bryant HE
    Front Mol Biosci; 2020; 7():191. PubMed ID: 33005627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1.
    Vélez-Cruz R; Manickavinayaham S; Biswas AK; Clary RW; Premkumar T; Cole F; Johnson DG
    Genes Dev; 2016 Nov; 30(22):2500-2512. PubMed ID: 27940962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanisms of regulaion of transcription by PARP1].
    Maliuchenko NV; Kulaeva OI; Kotova E; Chupyrkina AA; Nikitin DV; Kirpichnikov MP; Studitskiĭ VM
    Mol Biol (Mosk); 2015; 49(1):99-113. PubMed ID: 25916114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
    Jain PG; Patel BD
    Eur J Med Chem; 2019 Mar; 165():198-215. PubMed ID: 30684797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Targeted Agents in Gynecologic Cancers: Synthetic Lethality, Homologous Recombination Deficiency, and PARP Inhibitors.
    Liu FW; Tewari KS
    Curr Treat Options Oncol; 2016 Mar; 17(3):12. PubMed ID: 26931795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast.
    Perkins E; Sun D; Nguyen A; Tulac S; Francesco M; Tavana H; Nguyen H; Tugendreich S; Barthmaier P; Couto J; Yeh E; Thode S; Jarnagin K; Jain A; Morgans D; Melese T
    Cancer Res; 2001 May; 61(10):4175-83. PubMed ID: 11358842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
    Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X
    BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia.
    Oei AL; van Leeuwen CM; Ahire VR; Rodermond HM; Ten Cate R; Westermann AM; Stalpers LJA; Crezee J; Kok HP; Krawczyk PM; Kanaar R; Franken NAP
    Oncotarget; 2017 Apr; 8(17):28116-28124. PubMed ID: 28427225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel crosstalk between BRCA1 and poly (ADP-ribose) polymerase 1 in breast cancer.
    Li D; Bi FF; Chen NN; Cao JM; Sun WP; Zhou YM; Li CY; Yang Q
    Cell Cycle; 2014; 13(21):3442-9. PubMed ID: 25485588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(ADP-ribose) polymerase-1 (PARP1) and p53 labelling index correlates with tumour grade in meningiomas.
    Csonka T; Murnyák B; Szepesi R; Kurucz A; Klekner Á; Hortobágyi T
    Folia Neuropathol; 2014; 52(2):111-20. PubMed ID: 25118896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F1 loss induces spontaneous tumour development in Rb-deficient epidermis.
    Costa C; Santos M; Martínez-Fernández M; Dueñas M; Lorz C; García-Escudero R; Paramio JM
    Oncogene; 2013 Jun; 32(24):2937-51. PubMed ID: 22890321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Targeting of
    Fang E; Wang X; Yang F; Hu A; Wang J; Li D; Song H; Hong M; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
    Adv Sci (Weinh); 2019 Oct; 6(19):1900581. PubMed ID: 31592410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma.
    Majuelos-Melguizo J; Rodríguez MI; López-Jiménez L; Rodríguez-Vargas JM; Martí Martín-Consuegra JM; Serrano-Sáenz S; Gavard J; de Almodóvar JM; Oliver FJ
    Oncotarget; 2015 Mar; 6(7):4790-803. PubMed ID: 25576921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression.
    Wang Y; Deng O; Feng Z; Du Z; Xiong X; Lai J; Yang X; Xu M; Wang H; Taylor D; Yan C; Chen C; Difeo A; Ma Z; Zhang J
    Oncogene; 2016 Mar; 35(11):1363-72. PubMed ID: 26234677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma.
    Chornenkyy Y; Agnihotri S; Yu M; Buczkowicz P; Rakopoulos P; Golbourn B; Garzia L; Siddaway R; Leung S; Rutka JT; Taylor MD; Dirks PB; Hawkins C
    Mol Cancer Ther; 2015 Nov; 14(11):2560-8. PubMed ID: 26351319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.